Numetzah G13%e (Valine, Ornithine Hydrochloride, Alanine, Arginine, Cysteine, Histidine, Isoleucine, Leucine, Methio)

Numetzah G13%e, a mixture of essential and conditionally essential amino acids, supports metabolic pathways involved in protein synthesis and nitrogen balance.

• Protein‑energy malnutrition: helps restore amino‑acid balance and supports weight gain.
• Post‑operative recovery: provides substrates for tissue repair and wound healing.
• Chronic kidney disease (stable): offers supplemental amino acids under medical supervision to maintain nutritional status.
• Muscle wasting conditions: assists in preserving lean body mass during catabolic states.
• Elderly nutrition support: contributes to daily essential amino‑acid requirements.

• The product supplies a blend of essential amino acids that serve as direct substrates for ribosomal protein synthesis, activating the mTOR signaling pathway and promoting anabolic processes. By increasing plasma concentrations of these amino acids, it supports nitrogen balance, tissue repair, and metabolic functions without interacting with specific receptors.

Common Side Effects

• Nausea: mild gastrointestinal upset after ingestion.
• Abdominal discomfort: transient bloating or cramping.
• Diarrhea: loose stools in some individuals.
• Headache: occasional mild headache.
• Taste alteration: temporary metallic or bitter taste.
• Mild hyperammonemia: slight rise in blood ammonia levels.

Serious or Rare Side Effects

• Allergic reaction: rash, itching, or swelling.
• Anaphylaxis: severe, potentially life‑threatening hypersensitivity.
• Severe hyperammonemia: marked increase in ammonia requiring medical attention.
• Metabolic acidosis: rare disturbance in acid‑base balance.
• Renal impairment: worsening kidney function in susceptible patients.
• Hepatic dysfunction: abnormal liver enzyme elevations.

When considering Numetzah G13%e, healthcare professionals should evaluate patient‑specific factors and monitor for adverse events.

• Assess renal function: adjust use in patients with impaired kidney function.
• Monitor liver enzymes: watch for signs of hepatic stress during therapy.
• Avoid in known hypersensitivity: discontinue if allergic signs appear.
• Use with caution in pregnancy: limited data, only if potential benefit outweighs risk.
• Store at ambient temperature: keep below 25°C, protect from moisture and direct sunlight.

Numetzah G13%e may interact with other agents that affect nitrogen metabolism or amino‑acid handling.

Major Interactions (Avoid)

• Concurrent high‑dose ammonia‑producing drugs: may exacerbate hyperammonemia.
• Renal dialysis: can remove amino acids, reducing therapeutic effect.

Moderate Interactions (Monitor Closely)

• Antibiotics altering gut flora: may change amino‑acid absorption.
• Insulin therapy: amino‑acid load can influence glucose homeostasis.
• Diuretics: may affect electrolyte balance when combined with amino‑acid supplementation.